Astrana Health, Inc. $ASTH Shares Sold by SteelPeak Wealth LLC

SteelPeak Wealth LLC reduced its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 3.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 559,937 shares of the company’s stock after selling 20,000 shares during the period. SteelPeak Wealth LLC owned approximately 1.01% of Astrana Health worth $13,730,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Signaturefd LLC raised its position in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares during the last quarter. Strs Ohio acquired a new stake in shares of Astrana Health in the fourth quarter worth $40,000. Tower Research Capital LLC TRC increased its stake in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the period. Finally, State of Wyoming purchased a new position in shares of Astrana Health during the second quarter worth $132,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. BTIG Research boosted their price objective on Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a report on Tuesday. Truist Financial raised their target price on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Barclays upgraded Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Needham & Company LLC boosted their price target on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a report on Friday, May 8th. Finally, TD Cowen upped their price objective on Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $47.86.

Astrana Health Price Performance

Astrana Health stock opened at $45.10 on Friday. The stock has a market capitalization of $2.51 billion, a P/E ratio of 73.93 and a beta of 0.89. The company’s fifty day moving average price is $41.29 and its 200 day moving average price is $31.15. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $51.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The business had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the firm posted $0.42 earnings per share. The company’s revenue was up 55.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.